Monopar Therapeutics Inc (NASDAQ: MNPR): The Best-Of-Breed For Investing?
Currently, there are 12.95M common shares owned by the public and among those 6.37M shares have been available to trade. Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, […]
Stick With Monopar Therapeutics Inc (MNPR). The Bull Are Alive And Well
Currently, there are 12.95M common shares owned by the public and among those 6.37M shares have been available to trade. Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, […]